Comprehensive Untargeted Lipidomic Profiling of Third Generation Lentiviral Vectors and Packaging Cells
Jeffrey Smith,Joshua Roberts,Elena Godbout,Jocelyn Menard,Christopher Boddy,Jean-Simon Diallo
DOI: https://doi.org/10.26434/chemrxiv-2024-r7bd9
2024-03-25
Abstract:Lentiviral Vectors (LV) are emerging tools for genetic therapies and novel cancer treatments. While effective, LV-based therapies have extremely large costs associated with their manufacturing and delivery. LV technology descends from human immunodeficiency virus (HIV), whose lipid envelope has been previously measured and shown to have a direct impact on its transduction efficiency. We developed a rapid, robust, and sensitive untargeted lipidomics pipeline to analyze novel LV biotherapeutic products and demonstrate its utility on HEK 293T packaging cells and concentrated culture media containing LV. The impact of 48 hours of LV production on the lipidome of HEK 293T cells was measured and compared to the expression of Vesicular stomatitis virus G protein (VSV G) over the same timeframe. 151 lipids were identified in HEK 293T packaging cells, 84 of which had fold changes with FDR-corrected P<0.05 compared to HEK 293T treated with media. It was found that fold changes with FDR-adjusted P<0.05 after VSV G expression and LV production were highly correlated (R2=0.89). Concentrating LV in culture media led to the identification of 102 lipids, half of which being determined to be unique LV virion lipids after subtracting the media lipidome. Our approach can be readily used to study the lipid dynamics of large-scale LV production and be rapidly translated into targeted methods to quantify individual lipid components or applied to other viral vector platforms.
Chemistry
What problem does this paper attempt to address?
This paper mainly discusses the extensive applications of third-generation lentiviral vectors (LV) in gene therapy and cancer treatment, pointing out the problem of high manufacturing and distribution costs. In this study, the authors developed a rapid, robust, and sensitive non-targeted lipidomics method for analyzing novel LV biopharmaceutical products, with a particular focus on HEK 293T packaging cells and concentrated culture medium containing LV. Using this method, they found that LV production had a highly correlated impact on the lipidome of HEK 293T cells with VSV G protein expression and identified specific lipid components in LV viral particles. This method is expected to be used for lipid dynamics studies in large-scale LV production processes to optimize manufacturing processes, reduce costs, and serve as a means of quality control. Additionally, this work provides a reference for lipid analysis in other viral vector platforms.